Thomas D Albright

Title: Inventor Thomas D. Albright: Pioneering Neuropathology Evaluation

Introduction

Thomas D. Albright is a prominent inventor based in La Jolla, California, known for his innovative contributions to the field of neuropathology. With a focus on developing methods, systems, and devices for evaluating neurological disorders, Albright's work aims to enhance understanding and treatment options for various cognitive and sensory functions.

Latest Patents

Albright holds a patent for a groundbreaking invention titled "Systems and Methods for Evaluation of Neuropathologies." This patent introduces methods to assess vulnerability, disease progression, and treatments in neuropathologies. The core of this invention involves selecting a profile category aimed at assessing cognitive or sensory functions related to neurological or neuropsychiatric disorders. It outlines a method of presenting a sequence of stimuli to a subject while acquiring physiological signals before, during, and after the stimuli presentation. The resulting physiological data is processed to generate an informative set of quantitative values tied to the selected profile category.

Career Highlights

Throughout his career, Thomas D. Albright has worked at respected institutions such as the University of California and the Salk Institute for Biological Studies. His academic and research roles have allowed him to delve deeply into the complexities of neuropathologies, forming a bridge between innovative research and practical applications.

Collaborations

Albright has collaborated with notable colleagues in his field, including Todd Prentice Coleman and Marcela Mendoza. These partnerships have fostered an environment of shared knowledge and innovation, contributing to advancements in the understanding of neurological disorders.

Conclusion

Thomas D. Albright's contributions to the evaluation of neuropathologies through his innovative inventions demonstrate a commitment to improving diagnostic and treatment methodologies. His work continues to impact the field of neuroscience, offering new avenues for research and understanding of complex neurological disorders.